Canada markets closed

Can-Fite BioPharma Ltd. (CANF)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.0200+0.1378 (+15.62%)
At close: 04:00PM EDT
0.9300 -0.09 (-8.82%)
After hours: 07:40PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 24.32M
Enterprise Value 7.73M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)20.55
Price/Book (mrq)2.00
Enterprise Value/Revenue 8.49
Enterprise Value/EBITDA -0.59

Trading Information

Stock Price History

Beta (5Y Monthly) 1.65
52-Week Change 3-61.40%
S&P500 52-Week Change 3-11.08%
52 Week High 32.6000
52 Week Low 30.7800
50-Day Moving Average 30.9206
200-Day Moving Average 31.2053

Share Statistics

Avg Vol (3 month) 3133.37k
Avg Vol (10 day) 3161.81k
Shares Outstanding 527.19M
Implied Shares Outstanding 6N/A
Float 827.18M
% Held by Insiders 10.00%
% Held by Institutions 11.40%
Shares Short (May 30, 2022) 4385.19k
Short Ratio (May 30, 2022) 44.03
Short % of Float (May 30, 2022) 4N/A
Short % of Shares Outstanding (May 30, 2022) 41.42%
Shares Short (prior month Apr 28, 2022) 4479.72k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 09, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3May 09, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-1,433.08%

Management Effectiveness

Return on Assets (ttm)-53.29%
Return on Equity (ttm)-137.90%

Income Statement

Revenue (ttm)910k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)38.50%
Gross Profit (ttm)853k
EBITDA -13.03M
Net Income Avi to Common (ttm)-15.76M
Diluted EPS (ttm)-0.7500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)16.7M
Total Cash Per Share (mrq)0.61
Total Debt (mrq)109k
Total Debt/Equity (mrq)0.91
Current Ratio (mrq)6.09
Book Value Per Share (mrq)0.45

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A